Elkfork Partners’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Elkfork Partners’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$22K	Buy	+1,474	New	+$22.9K	﹤0.01%	1027

Other funds holding STSA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Elkfork Partners's STSA Position: Q3 2019 in Review

Elkfork Partners opened a new position in Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q3 2019: 1,474 shares worth $22K. The stake represents ﹤0.01% of the portfolio and ranks #1027 among its holdings.

30 funds tracked by Wall St. Rank hold STSA as of Q3 2019.

Elkfork Partners held 1,474 shares of Satsuma Pharmaceuticals, Inc. Common Stock worth $22K as of Q3 2019.
Satsuma Pharmaceuticals, Inc. Common Stock was a new Elkfork Partners position in Q3 2019.
Satsuma Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Elkfork Partners's portfolio in Q3 2019, its #1027 holding.
30 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.